Table 1 IC50 values for MLN2238 in HCC cells

From: Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

 

IC50 (nM, mean ± S.D.)

 

HepG2

Hep3B

SNU475

48 h

570 ± 22

201 ± 31

387 ± 36

72 h

281 ± 14

260 ± 24

428 ± 81

Back to article page